Earnings Call · Q2 FY2021·2021-08-05

Q2 21EPS +10.24%·Rev n/aQ1 21EPS +14.98%·Rev n/aQ4 20EPS -97.14%·Rev n/aQ3 20EPS -59.46%·Rev n/a⚠ consensus missing

Moderna, Inc. MRNA

Lavina Talukdar — Head of Investor Relations

Stéphane Bancel — Chief Executive Officer

Corinne Le Goff — Chief Commercial Officer

David Meline — Chief Financial Officer

Jackie Miller — SVP, Infectious Diseases

Stephen Hoge — President

−0.7%1d on move date−1.3% vs SPY3d+15.6%5d−8.0%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MRNA calls or request research access.

More MRNA calls Browse calls Request research access